These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

851 related items for PubMed ID: 24799326

  • 1. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
    Johnson S, Louie TJ, Gerding DN, Cornely OA, Chasan-Taber S, Fitts D, Gelone SP, Broom C, Davidson DM, Polymer Alternative for CDI Treatment (PACT) investigators.
    Clin Infect Dis; 2014 Aug 01; 59(3):345-54. PubMed ID: 24799326
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differences of the Fecal Microflora With Clostridium difficile Therapies.
    Louie TJ, Byrne B, Emery J, Ward L, Krulicki W, Nguyen D, Wu K, Cannon K.
    Clin Infect Dis; 2015 May 15; 60 Suppl 2():S91-7. PubMed ID: 25922407
    [Abstract] [Full Text] [Related]

  • 4. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR.
    Am J Geriatr Pharmacother; 2012 Feb 15; 10(1):14-24. PubMed ID: 22260856
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG, Palmer HR, Shah DN, Le F, Beyda ND, Jiang Z, Garey KW.
    J Hosp Infect; 2013 Sep 15; 85(1):28-32. PubMed ID: 23834988
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Luminal Toxin-Binding Agents for Clostridium difficile Infection.
    McCoy RM, Klick A, Hill S, Dull RB.
    J Pharm Pract; 2016 Aug 15; 29(4):361-7. PubMed ID: 25613056
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS.
    Surg Infect (Larchmt); 2011 Jun 15; 12(3):235-9. PubMed ID: 21767157
    [Abstract] [Full Text] [Related]

  • 15. Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
    Louie T, Nord CE, Talbot GH, Wilcox M, Gerding DN, Buitrago M, Kracker H, Charef P, Cornely OA.
    Antimicrob Agents Chemother; 2015 Oct 15; 59(10):6266-73. PubMed ID: 26248357
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for Clostridium difficile.
    Early CR, Park JM, Dorsch MP, Pogue KT, Hanigan SM.
    Transpl Infect Dis; 2016 Oct 15; 18(5):714-720. PubMed ID: 27501504
    [Abstract] [Full Text] [Related]

  • 18. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.
    Fischer M, Sipe BW, Rogers NA, Cook GK, Robb BW, Vuppalanchi R, Rex DK.
    Aliment Pharmacol Ther; 2015 Aug 15; 42(4):470-6. PubMed ID: 26096320
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.